%PDF-1.4
%
60 0 obj
<>
endobj
57 0 obj
<>
endobj
106 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-11-24T15:59:28Z
2024-03-28T09:11:44-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T09:11:44-07:00
application/pdf
Heather
200418.may
uuid:5aa7fbbd-1dd2-11b2-0a00-b908277d8900
uuid:5aa7fbbf-1dd2-11b2-0a00-d30000000000
endstream
endobj
46 0 obj
<>
endobj
47 0 obj
<>
endobj
61 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
15 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
18 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
26 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
34 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
136 0 obj
[140 0 R]
endobj
137 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
-0.00011 Tc 0.22861 Tw 10 0 0 10 54 713.1616 Tm
[(item and dif)17.7 (ficult 8 item HAQ are required before firm)]TJ
0 Tc 0.02499 Tw 0 -1.2 TD
(recommendations can be made.)Tj
-0.00011 Tc 0.007 Tw 1.2 -1.2 Td
[(In the end, there are tradeof)17.7 (fs. )17.7 (The MHAQ is shorter and)]TJ
0 Tc 0.11099 Tw -1.2 -1.2 Td
[(mar)17.8 (ginally easier to score. But this comes at the prices of)]TJ
0.27119 Tw T*
(less sensitivity to functional loss and less sensitivity to)Tj
0.26559 Tw T*
[(change. )17.8 (Where questionnaire length is not an important)]TJ
0.0598 Tw T*
(consideration, the HAQ is a better choice, but where space)Tj
0.0732 Tw T*
(and time are important the MHAQ is able to capture func-)Tj
0.06979 Tw T*
(tional loss, but with some loss of sensitivity to change and)Tj
-0.0152 Tw T*
[(the ability to detect mild functional loss. )17.8 (The dif)17.8 (ficult 8 item)]TJ
0.17661 Tw T*
(HAQ is an intriguing additional choice that is worthy of)Tj
-0.00011 Tc 0.02499 Tw T*
[(further study)64.8 (.)]TJ
/TT1 1 Tf
0 Tw 0 -2.4 TD
(ACKNOWLEDGMENT)Tj
/TT0 1 Tf
0.08701 Tw 8 0 0 8 54 547.1616 Tm
[(The author thanks Professor Ben D. )17.8 (W)39.7 (right of the University of Chicago)]TJ
0 Tc 0.02499 Tw 0 -1.25 TD
(for his instruction and helpful advice)Tj
0 Tw 10 0 0 10 172.9571 537.1616 Tm
(.)Tj
/TT1 1 Tf
-0.00011 Tc -11.8957 -2.4 Td
(REFERENCES)Tj
/TT0 1 Tf
0.02499 Tw 8 0 0 8 61 503.1616 Tm
[(1.)-875.1 (Felson DT)73.9 (, )54.8 (Anderson JJ, Boers M, et al. )17.7 (The )54.8 (American College of)]TJ
0 Tc 1.675 -1.25 Td
(Rheumatology preliminary core set of disease activity measures for)Tj
T*
[(rheumatoid arthritis clinical trials. )17.8 (The Committee on Outcome)]TJ
-0.00011 Tc T*
[(Measures in Rheumatoid )54.8 (Arthritis Clinical )17.7 (T)34.8 (rials. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1993;36:729-40.)Tj
0.0249 Tw -1.675 -1.25 Td
[(2.)-875 (V)111.1 (angestel )54.8 (AM, )54.8 (Anderson JJ, van Riel PLCM, et al. )54.8 (ACR and)]TJ
1.675 -1.25 Td
(EULAR improvement criteria have comparable validity in)Tj
T*
[(rheumatoid arthritis trials. J Rheumatol 1999;26:705-1)36.9 (1.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(3.)-875.1 (Boers M, )17.7 (T)34.8 (ugwell P)110.7 (, Felson DT)73.9 (, et al. )17.7 (WHO and ILAR core)]TJ
0 Tc 1.675 -1.25 Td
(endpoints for symptom modifying antirheumatic drugs in RA)Tj
T*
(clinical trials. J Rheumatol 1994;21 Suppl 41:86-9.)Tj
-1.675 -1.25 Td
[(4.)-875 (Scott DL, Panayi GS, van Riel PLCM, et al. Disease activity in)]TJ
1.675 -1.25 Td
(rheumatoid arthritis \227 Preliminary Report of the Consensus Study)Tj
T*
[(Group of the European )17.8 (W)79.8 (orkshop for Rheumatology Research. Clin)]TJ
T*
(Exp Rheumatol 1992;10:521-5.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(5.)-875.1 (W)79.7 (olfe F)79.7 (, Lassere M, van der Heijde D, et al. Preliminary core set of)]TJ
0 Tc 1.675 -1.25 Td
(domains and reporting requirements for longitudinal observational)Tj
T*
[(studies in rheumatology)64.9 (. J Rheumatol 1999;26:484-9.)]TJ
-1.675 -1.25 Td
[(6.)-875 (W)79.8 (olfe F)79.8 (,)0.1 ( Pincus )17.7 (T)74 (. Current comment \227 Listening to the patient \227)]TJ
1.675 -1.25 Td
[(A)-219.8 (practical guide to self-report questionnaires in clinical care.)]TJ
T*
(Arthritis Rheum 1999;42:1797-808.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(7.)-875.1 (Fries JF)79.7 (, Spitz PW)91.7 (, Kraines RG, Holman HR. Measurement of)]TJ
0 Tc 1.675 -1.25 Td
[(patient outcome in arthritis. )54.9 (Arthritis Rheum 1980;23:137-45.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(8.)-875.1 (Pincus )17.7 (T)73.9 (, Summey JA, Soraci SA)-220.2 (Jr)39.7 (, )17.7 (W)79.7 (allston KA, Hummon NP)110.7 (.)]TJ
0 Tc 1.675 -1.25 Td
(Assessment of patient satisfaction in activities of daily living using)Tj
-0.00011 Tc T*
[(a modified Stanford Health )54.8 (Assessment Questionnaire. )54.8 (Arthritis)]TJ
0 Tc T*
(Rheum 1983;26:1346-53.)Tj
-1.675 -1.25 Td
[(9.)-875 (Ziebland S, Fitzpatrick R, Jenkinson C, Mowat )54.8 (A. Comparison of)]TJ
1.675 -1.25 Td
(two approaches to measuring change in health status in rheumatoid)Tj
-0.00011 Tc 33 61.421 Td
[(arthritis: the Health )54.8 (Assessment Questionnaire \(HAQ\) and modified)]TJ
0 Tc T*
[(HAQ. )54.9 (Ann Rheum Dis 1992;51:1202-5.)]TJ
-2.175 -1.25 Td
[(10.)-875 (Stucki G, Stucki S, Bruhlmann P)110.8 (, Michel BA. Ceiling ef)17.8 (fects of the)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(Health )54.8 (Assessment Questionnaire and its modified version in some)]TJ
0 Tc T*
[(ambulatory rheumatoid arthritis patients. )54.8 (Ann Rheum Dis)]TJ
0 Tw T*
(1995;54:461-5.)Tj
-0.00011 Tc 0.02499 Tw -2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (Serrano MAB, Fabregat JB, Garzon JO. Should the MHAQ ever be)]TJ
0 Tc 2.1381 -1.25 Td
[(used? )54.9 (Ann Rheum Dis 1996;55:271.)]TJ
-2.175 -1.25 Td
[(12.)-875 (Stucki G, Stucki S, Bruhlmann P)110.8 (,)0.1 ( Michel BA. Should the MHAQ)]TJ
2.175 -1.25 Td
[(ever be used? [reply to letter]. )54.9 (Ann Rheum Dis 1996;55:271-2.)]TJ
-2.175 -1.25 Td
[(13.)-875 (T)69.8 (ennant )54.8 (A, R)39.8 (yser L, Stucki G, )17.7 (W)79.8 (olfe F)79.8 (. )54.8 (An 8-item international)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(version of the HAQ: )17.7 (The Inter)19.7 (-HAQ [abstract]. )54.8 (Arthritis Rheum)]TJ
0 Tc T*
(1999;42 Suppl: S74.)Tj
-2.175 -1.25 Td
[(14.)-875 (T)69.8 (ennant )54.8 (A, R)39.8 (yser L, Stucki G, )17.7 (W)79.8 (olfe F)79.8 (. )54.8 (Applying item response)]TJ
-0.00011 Tc 2.175 -1.25 Td
(theory to measurement issues: Deriving a short version of the)Tj
T*
[(Stanford Health )54.8 (Assessment Questionnaire \(HAQ\) \227 the RA-)]TJ
T*
(HAQ. \(Submitted\) )Tj
0 Tc -2.175 -1.25 Td
[(15.)-875 (McNamara )17.8 (T)74 (. Measuring second language performance. London:)]TJ
2.175 -1.25 Td
(Longman; 1996.)Tj
-2.175 -1.25 Td
[(16.)-875 (Andrich D. Rasch models for measurement. In: Quantitative)]TJ
2.175 -1.25 Td
(applications in the social sciences. Newbury Park: Sage)Tj
T*
(Publications; 1988.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(17.)-875.1 (W)39.7 (right BD, Masters GN. Rating scale analysis: Rasch)]TJ
0 Tc 2.175 -1.25 Td
(measurement. Chicago: Mesa; 1982.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(18.)-875.1 (Katz JN, Larson MG, Phillips CB, Fossel )54.8 (AH, Liang MH.)]TJ
0 Tc 2.175 -1.25 Td
(Comparative measurement sensitivity of short and longer health)Tj
T*
(status instruments. Med Care 1992;30:917-25.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(19.)-875.1 (W)79.7 (olfe F)79.7 (, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW)91.7 (, Fries)]TJ
0 Tc 2.175 -1.25 Td
[(JF)79.8 (. )17.8 (The clinical value of the Stanford Health )54.9 (Assessment)]TJ
T*
(Questionnaire Functional Disability Index in patients with)Tj
T*
(rheumatoid arthritis. J Rheumatol 1988;15:1480-8.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(20.)-875.1 (Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative)]TJ
0 Tc 2.175 -1.25 Td
[(measurement ef)17.8 (ficiency and sensitivity of five health status)]TJ
-0.00011 Tc T*
[(instruments for arthritis research. )54.8 (Arthritis Rheum 1985;28:542-7.)]TJ
0 Tc -2.175 -1.25 Td
[(21.)-875 (Raftery )54.9 (AE. Bayesian model selection in social research. In:)]TJ
2.175 -1.25 Td
[(Marsden PV)128.9 (, editor)54.9 (. Sociological methodology)64.9 (. Oxford: Basil)]TJ
T*
[(Blackwell; 2000:1)36.9 (1)36.9 (1-63.)]TJ
-2.175 -1.25 Td
[(22.)-875 (Long JS. Regression models for categorical and limited dependent)]TJ
2.175 -1.25 Td
[(variables. )17.8 (Thousand Oaks: Sage Publications; 1997.)]TJ
-2.175 -1.25 Td
[(23.)-875 (Stata Corporation. Stata statistical software: Release 6.0. College)]TJ
2.175 -1.25 Td
[(Station, )17.8 (TX: Stata Corporation; 1999.)]TJ
-2.175 -1.25 Td
[(24.)-875 (A)-219.8 (user)-36.9 (\222)55.2 (s guide to BIGSTEPS: Rasch model computer program.)]TJ
-0.00011 Tc 2.175 -1.25 Td
(Chicago: Mesa Press; 1997.)Tj
0 Tc -2.175 -1.25 Td
[(25.)-875 (Fischer GH, Molenaar IW)91.8 (. Rasch models: foundations, recent)]TJ
2.175 -1.25 Td
[(developments, and applications. New )36.8 (Y)100.1 (ork: Springer)19.8 (-V)110.8 (erlag; 1995.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(26.)-875.1 (Nunnally JC, Bernstein IH. Psychometric theory)64.8 (. 3rd ed. New )36.7 (Y)100 (ork:)]TJ
2.175 -1.25 Td
(McGraw-Hill; 1994.)Tj
-2.175 -1.25 Td
[(27.)-875.1 (W)39.7 (insteps )17.7 (V)111 (e)-0.1 (rsion 3.05. Chicago: Mesa Press; 2000.)]TJ
ET
0 0 0 0 scn
465 777 92 -27 re
f*
468 770 90 -25 re
f*
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
0 0 0 1 scn
/TT2 1 Tf
8 0 0 8 54.5 35.9844 Tm
[(W)91.9 (olfe: Which HAQ is best?)]TJ
0 Tc 0 Tw 61.4375 -0.0313 Td
(989)Tj
ET
0 0 0 0 scn
/GS0 gs
105.28 59.69 407.5 -10.83 re
f*
0.5 w
105.28 59.69 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2001. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
89 0 obj
<>
endobj
111 0 obj
<>
endobj
68 0 obj
<>
endobj
37 0 obj
<>
endobj
65 0 obj
<>
endobj
63 0 obj
<>
endobj
83 0 obj
<>stream
HVpMg}9ބ(ysHIn^#THR{!h*4d\Qbc+:mi*ztMcZtUYܳsT;?~ mPy_K[7LQJ[ij~na4u_i]bGXX{>ΣRɮk'o}SqT+ ?'ߵbނ=ߐao*#c~P||DAex\ ME
h;xUΚ;ϺK
sJ+~ Q,ekhT Γ`O%oDžZXE\tC
Y1*<MXF{CfcqvIb=b(/AIۿr:bca,qX[gpJ|*Fz}QwڪTw!ZMQA\:üh8c.:X
"E<ݑǝc9zGox0Q@XDvd9OvLk1@VWkhDtOrwa560p*1Hyb ҫe^5JbG+"I!~D1~
D=1='"Kl%Y&g;UQWW!$p}|Fpn 5
{>gg. Hh)D7W⢌1Ґ%%UROW5opu{*f[2ܮL%̽^c rl ۍrϹI wq("DGHHnVm'ƈ*XԈ%'O1V2GIr\.?Y.op%QqGH")ZVv}|7/8!89XBVer@n['i}8*H%IUF(2[YlWv(+&XyVj}zNKkZ6S{Shh^a:
Xzl[i?}# ҋ˸
,!O-a> ?r8Ɠb1뤖DR5+$֍0ރ[Ό>:հ/8jcқ=ewZjK^LNjʥw霘)c\lLt/j&u0CS)5}3dcp~
?LmL2ӟвgfKSK`w5tD71\2
u)Z!
7|1eruǶ'bIIH m$BJO-18(?圈+sƤGvj[K;ZIYeݡ>RWֶA}Ug
\"c
)B;J"RsCڜ]HݔUd#:$OXg|;Wۿ
͘I.Gϧm
鸒hWzYe/\Yy9?)/h)5Q=?WzHΛHH8:`Y+ҕd_[/KadcK c#lZFl&1!Ĵƀ!N$0$j\W%0vNH:53f4iK-J:L9ٳ{Dm8~Ka5zŽ_;gPԋA p8>ZvDwmVFJeۉrQ̷0˰fX> gp7(G@ֈ
G|0w`f7XbdΞ=^;@`n_$paٔߓ|FFHsu &cGr2oXI(W,~>?_;cd-R Z$[;oc,w!s0N%FsJޑ "E@@o#tOi¤&*QN}4C%}ZjSI/U% ,*`V &